278 related articles for article (PubMed ID: 18693718)
1. Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields.
Durán A; Martínez GC; Pastor M
J Chem Inf Model; 2008 Sep; 48(9):1813-23. PubMed ID: 18693718
[TBL] [Abstract][Full Text] [Related]
2. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
Rajamani R; Good AC
Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
[TBL] [Abstract][Full Text] [Related]
3. Flexible 3D pharmacophores as descriptors of dynamic biological space.
Nettles JH; Jenkins JL; Williams C; Clark AM; Bender A; Deng Z; Davies JW; Glick M
J Mol Graph Model; 2007 Oct; 26(3):622-33. PubMed ID: 17395510
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of hydration in drug design.
Mancera RL
Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
[TBL] [Abstract][Full Text] [Related]
5. Pocket extraction on proteins via the Voronoi diagram of spheres.
Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS
J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220
[TBL] [Abstract][Full Text] [Related]
6. Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR.
Totrov M
Chem Biol Drug Des; 2008 Jan; 71(1):15-27. PubMed ID: 18069986
[TBL] [Abstract][Full Text] [Related]
7. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
8. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
Mor M; Rivara S; Lodola A; Lorenzi S; Bordi F; Plazzi PV; Spadoni G; Bedini A; Duranti A; Tontini A; Tarzia G
Chem Biodivers; 2005 Nov; 2(11):1438-51. PubMed ID: 17191945
[TBL] [Abstract][Full Text] [Related]
9. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
Mohr JA; Jain BJ; Obermayer K
J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
[TBL] [Abstract][Full Text] [Related]
10. A novel in silico approach to drug discovery via computational intelligence.
Hecht D; Fogel GB
J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
[TBL] [Abstract][Full Text] [Related]
11. Towards improving compound selection in structure-based virtual screening.
Waszkowycz B
Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
[TBL] [Abstract][Full Text] [Related]
12. A novel method for protein-ligand binding affinity prediction and the related descriptors exploration.
Li S; Xi L; Wang C; Li J; Lei B; Liu H; Yao X
J Comput Chem; 2009 Apr; 30(6):900-9. PubMed ID: 18785151
[TBL] [Abstract][Full Text] [Related]
13. Incorporating molecular shape into the alignment-free Grid-Independent Descriptors.
Fontaine F; Pastor M; Sanz F
J Med Chem; 2004 May; 47(11):2805-15. PubMed ID: 15139758
[TBL] [Abstract][Full Text] [Related]
14. A self-organizing algorithm for molecular alignment and pharmacophore development.
Bandyopadhyay D; Agrafiotis DK
J Comput Chem; 2008 Apr; 29(6):965-82. PubMed ID: 17999384
[TBL] [Abstract][Full Text] [Related]
15. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.
Nettles JH; Jenkins JL; Bender A; Deng Z; Davies JW; Glick M
J Med Chem; 2006 Nov; 49(23):6802-10. PubMed ID: 17154510
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ligand-based and structure-based 3D-QSAR approaches: a case study on (aryl-)bridged 2-aminobenzonitriles inhibiting HIV-1 reverse transcriptase.
Sciabola S; Carosati E; Baroni M; Mannhold R
J Med Chem; 2005 Jun; 48(11):3756-67. PubMed ID: 15916427
[TBL] [Abstract][Full Text] [Related]
17. Computational chemistry approaches to drug discovery in signal transduction.
Fischer PM
Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
[TBL] [Abstract][Full Text] [Related]
18. DASH: a novel analysis method for molecular dynamics simulation data. Analysis of ligands of PPAR-gamma.
Salt DW; Hudson BD; Banting L; Ellis MJ; Ford MG
J Med Chem; 2005 May; 48(9):3214-20. PubMed ID: 15857127
[TBL] [Abstract][Full Text] [Related]
19. From modeling to medicinal chemistry: automatic generation of two-dimensional complex diagrams.
Stierand K; Rarey M
ChemMedChem; 2007 Jun; 2(6):853-60. PubMed ID: 17436259
[TBL] [Abstract][Full Text] [Related]
20. In silico identification of bioisosteric functional groups.
Ertl P
Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
